SAB Biotherapeutics (SABS) Depreciation and Depletion (2023 - 2026)
SAB Biotherapeutics' Depreciation and Depletion was $22,000 in Q2 2026, unchanged from $22,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Depreciation and Depletion (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, SAB Biotherapeutics' Depreciation and Depletion was $100,883 through Jun 30, 2026, unchanged year-over-year; for FY2025, it came in at $100,000, unchanged from FY2024.
- Depreciation and Depletion shows a three-year compound annual growth rate of -6.5% (FY2022 to FY2025).
- In earlier years, Depreciation and Depletion was $100,000 in FY2024 (unchanged), $100,000 in FY2023 (-18.3%) and $122,449 in FY2022.
- Quarterly Depreciation and Depletion has moved between $22,000 (Q3 2023) and $34,883 (Q4 2025) over five years.
- Compared with a year earlier, Depreciation and Depletion was higher in 1 of the last eight quarters, with growth averaging 2.1%.
- The best year-over-year quarter for Depreciation and Depletion over five years was Q4 2024 (growth of 17.1%); the worst was Q1 2024 (a decline of 12.0%).
- Per Business Quant data, SABS's Depreciation and Depletion in the three quarters before Q2 2026 was $22,000 (Q1 2026), $34,883 (Q4 2025) and $22,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 194.00 Mn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 599.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | - |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 98.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | SAB Biotherapeutics | 255.49 Mn | 255.49 Mn | - | 22,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22,000.00 |
| Mar 31, 2026 | 22,000.00 |
| Dec 31, 2025 | 34,883.00 |
| Sep 30, 2025 | 22,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Mar 31, 2025 | 22,000.00 |
| Dec 31, 2024 | 34,882.00 |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 22,000.00 |
| Mar 31, 2024 | 22,000.00 |
| Dec 31, 2023 | 29,779.00 |
| Sep 30, 2023 | 22,000.00 |
| Jun 30, 2023 | 23,000.00 |
| Mar 31, 2023 | 25,000.00 |
API Access
SAB Biotherapeutics Depreciation and Depletion API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-depletion", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();